ArticleBMC cancer2025
Prognostic performance of the nutritional risk screening 2002 and the global leadership initiative on malnutrition in patients with lung cancer treated with immune checkpoint inhibitors.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials.Frontiers in immunology · 2026Pooled it
- TNF-α orchestrates ADAM metallopeptidase with thrombospondin type 1 motif 2 upregulation and extracellular matrix remodeling through multimodal signaling in osteosarcoma cells.Molecular biology reports · 2026Article
- Multidimensional modeling and stratification of nutritional risk in non-small cell lung cancer based on artificial intelligence-derived CT body composition phenotypes.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe Nutritional Risk Screening 2002 (NRS 2002) is used to identify patients at risk who may benefit from nutritional intervention, while the Global Leadership Initiative on Malnutrition (GLIM) criteria serve as a diagnostic tool for malnutrition. However, their impacts on response to immunotherapy in patients with lung cancer are unknown. Therefore, this study investigated the role of NRS 2002 and GLIM criteria in predicting overall survival (OS) in patients with lung cancer receiving immune checkpoint inhibitors (ICIs).
methodsThis retrospective study included 146 patients with lung cancer treated with ICIs. Nutritional risk was evaluated using the NRS 2002, while nutritional status was assessed using the GLIM criteria. The OS rates were analyzed using Kaplan-Meier curves and Cox proportional hazard analyses. Two nomograms based on NRS 2002 and GLIM criteria were established to predict OS. Kendall's Tau was used to determine the relationship between NRS 2002 scores and GLIM criteria.
resultsThe Kaplan-Meier survival revealed poor survival times in patients with nutritional risk (NRS 2002 score ≥ 3) and malnutrition as defined by the GLIM criteria. The multivariable Cox analyses identified that nutritional risk (hazard ratio [HR], 2.00, 95% confidence interval [CI]: 1.06-3.81, P = 0.033) and malnutrition (HR, 2.46, 95%CI: 1.28-4.77, P = 0.007) are independent factors predicting OS. Age, stage, NRS 2002 score, and GLIM criteria were used to develop the nomograms. Higher nomogram scores predicted significantly reduced OS (P < 0.0001). NRS 2002 scores and GLIM criteria showed a moderately strong positive correlation, with Kendall's tau = 0.709 (95% CI: 0.629-0.785; P < 0.001).
conclusionsNutritional risk and GLIM criteria-defined malnutrition are prognostic factors in patients with lung cancer receiving immunotherapy. NRS 2002 scores were significantly correlated with GLIM criteria in predicting diagnostic outcomes in lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.